Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.64 |
| ▸ | CA1 | P00915 | 2/20 | 0.60 |
| ▸ | CA2 | P00918 | 2/20 | 0.60 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA3 | P07451 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | CA4 | P22748 | 1/20 | 0.56 |
| ▸ | CA6 | P23280 | 1/20 | 0.56 |
| ▸ | CA5A | P35218 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.56 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.50 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3,5-Dimethoxybenzoic Acid SCHEMBL20592058 | 0.98 | RXRA (0.62) | RXRACA1CA2CA12CA3 | |
| 3,5-Dimethoxybenzoic Acid SCHEMBL5668197 | 0.98 | RXRA (0.62) | RXRACA1CA2CA12CA3 | |
| 3,5-Dimethoxybenzoic Acid SCHEMBL9426765 | 0.95 | RXRA (0.60) | RXRACA1CA2CA12CA3 | |
| SCHEMBL39734 | 0.95 | CA1 (0.60) | RXRACA1CA2CA12CA3 | |
| SCHEMBL25508690 | 0.93 | RXRA (0.58) | RXRACA1CA2CA12CA3 | |
| Hydrochloric Acid SCHEMBL19118500 | 0.93 | CA1 (0.58) | RXRACA1CA2CA12CA3 | |
| Hydrochloric Acid SCHEMBL3361588 | 0.93 | CA1 (0.58) | RXRACA1CA2CA12CA3 | |
| 3,5-Dimethoxybenzoic Acid SCHEMBL11236187 | 0.91 | RXRA (0.56) | RXRACA1CA2CA12CA3 | |
| SCHEMBL13725392 | 0.88 | RXRA (0.53) | RXRACA1CA2CA12CA3 | |
| 3,5-Dimethoxybenzoic Acid SCHEMBL6885267 | 0.88 | RXRA (0.53) | RXRACA1CA2CA12CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1335 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260002924-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2026-01-01 | — | — | US | claimed |
| US-20250341515-A1 | METABOLOMIC BIOMARKERS FOR ACUTE KIDNEY INJURY, ASSAYS, COMPOSITIONS AND METHODS OF USE THEREOF | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-11-06 | — | — | US | claimed |
| CN-119859148-A | Spiroteine framework compound and preparation method and application thereof | 安徽农业大学 | 2025-04-22 | — | — | CN | claimed |
| CN-119504367-A | Preparation method of benvimod | 承德医学院 | 2025-02-25 | — | — | CN | claimed |
| CN-117503839-B | Application of polyphenol extract of bald She Huangbo fruits in preparation of medicines with liver protection effect | 成都中医药大学 | 2025-01-14 | — | — | CN | claimed |
| EP-4477693-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | Korea Research Institute of Chemical Technology (KR) | 2024-12-18 | — | — | EP | claimed |
| US-12076316-B2 | Levorphanol prodrugs and processes for making and using them | ZEVRA THERAPEUTICS INC. | 2024-09-03 | — | — | US | claimed |
| CN-118420440-A | Preparation method of trans-resveratrol | 河北科技大学 | 2024-08-02 | — | — | CN | claimed |
| CN-116813454-B | Synthetic method of pterostilbene | 珠海市柏瑞医药科技有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-117503839-A | Application of polyphenol extract of bald She Huangbo fruits in preparation of medicines with liver protection effect | 成都中医药大学 | 2024-02-06 | — | — | CN | claimed |
| WO-1997027331-A2 | METHODS AND COMPOSITIONS FOR DETERMINING THE SEQUENCE OF NUCLEIC ACID MOLECULES | RAPIGENE, INC. (US) | 1997-07-31 | — | — | WO | claimed |
| US-5457192-A | Reducing by hydrogenating a levoglucosenone, blocking of hydroxyl group, oxidation, adding addition hydroxyl groups, deblocking; stereospecific | JAPAN TOBACCO INC. (JP) | 1995-10-10 | — | — | US | claimed |
| EP-0067770-B1 | TREATMENT OF MIGRAINE WITH TROPYL BENZOATE DERIVATIVES | MERRELL DOW FRANCE ET CIE (FR) | 1992-01-15 | — | — | EP | claimed |
| US-4845142-A | AND AROMATIC CARBOXYLIC ACID, INJECTION MOLDING | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-07-04 | — | — | US | claimed |
| EP-0318825-A2 | Process for the preparation of 4-dimethylamino-3,5-dimethoxy-benzoic acid methyl ester | F. HOFFMANN-LA ROCHE AG (CH) | 1989-06-07 | — | — | EP | claimed |
| EP-0241490-A1 | HERBICIDAL CYCLOHEXENE DERIVATIVES | Dunlena Pty. Limited (AU) | 1987-10-21 | — | — | EP | claimed |
| WO-1987002356-A1 | HERBICIDAL CYCLOHEXENE DERIVATIVES | DUNLENA PTY LIMITED (AU) | 1987-04-23 | — | — | WO | claimed |
| EP-0219343-A2 | Cyclohexane-1,3-dione derivatives having a herbicidal activity | Dunlena Pty. Limited (AU) | 1987-04-22 | — | — | EP | claimed |
| EP-0214158-A1 | ANTHELMINTIC PYRIDINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS | THE UPJOHN COMPANY (US) | 1987-03-18 | — | — | EP | claimed |
| WO-1986004582-A1 | ANTHELMINTIC PYRIDINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS | THE UPJOHN COMPANY (US) | 1986-08-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260002924-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | FGB, NR4A1, CYP2E1 | RXRA 927/4885CA1 2951/4885CA2 3093/4885 |
| US-12076316-B2 | Levorphanol prodrugs and processes for making and using them | OPRM1, OPRL1, OPRK1 | RXRA 1009/4885CA1 1503/4885CA2 3018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.